Indication

Fibrinolysis Shutdown

1 clinical trial

1 product

Clinical trial

A Phase 2 Safety, Dose-finding and Efficacy Study Evaluating Viscoelastic Testing (VET) Guided Tissue Plasminogen Activator (tPA) Treatment in Critically-ill Pro-thrombotic Acute Respiratory Failure

Status: Recruiting, Estimated PCD: 2026-05-01

Product